Drug | Indication | Dose | Route of Administration | Duration of Treatment |
Phylloquinone (Vitamin K1) | Prophylaxis for Vitamin K deficiency bleeding | 1 mg | Intramuscularly | 1 dose |
Oxytocin (Pitocin) | Postpartum hemorrhage only | 10 Units/ml | Intramuscularly only | 1-2 doses. Transport to hospital required if more than two (2) doses are administered. |
Misoprostol Note: This is an appropriate off label use of this drug. | Postpartum hemorrhage only | 200 microgram tabs, at 800 micrograms per dose (4 tabs) | Rectal or sublingual, or may be used as 1/2 rectally and 1/2 sublingually | 1-2 doses. Transport to hospital required if more than 2 doses are administered. Not to exceed 800 micrograms. |
Methylergonovine (Methergine) | Postpartum hemorrhage only | 0.2mg | Intramuscular or orally | Single dose. Every six hours, may repeat 3 times. Contraindicated in hypertension and Raynaud's Disease. |
Lidocaine HCL 1% or 2% | Local anesthetic for use during postpartum repair of lacerations or episiotomy | Maximum 50 ml (1%) Maximum 15 ml (2%) | Precutaneous infiltration only | Completion of repair |
Penicillin G (Recommended) | Group B Strep Prophylaxis | 5 million units initial dose, then 2.5 million units every 4 hours until birth | IV in >=100 ml LR, NS or D5LR | Until birth of baby |
Ampicillin Sodium (Alternative) | Group B Strep Prophylaxis | 2 grams initial dose, then 1 gram every 4 hours until birth | IV in >=100ml NS | Until birth of baby |
Cefazolin Sodium | Group B Strep Prophylaxis | 2 grams initial dose, then 1 gram every 8 hours | IV in >=100 ml LR, NS or D5LR | Until birth of baby |
Clindamycin Phosphate | Group B Strep Prophylaxis | 900 mg every 8 hours | IV in >=100 ml NS or LR | Until birth of baby |
Lactated Ringers (LR) | To administer group B Strep Prophylaxis | Intravenous catheter | ||
5% Dextrose in Lactated Ringer's solution (D5LR) | To administer group B Strep Prophylaxis | Intravenous catheter | ||
0.9% Sodium Chloride (NS) | To administer group B Strep Prophylaxis | Intravenous catheter | ||
Oxygen | Maternal/Fetal Distress, or Neonatal Resuscitation | 10-12 L/min 10 L/min | Mask or bag and mask | Until stabilization is achieved or transfer to a hospital is complete |
0.5% Erythromycin Ophthalmic Ointment | Prophylaxis of Neonatal Opthalmia | 1 cm ribbon in each eye | Topical | 1 dose |
Rh(D) Immune Globulin | Prevention of RH(D) sensitization in Rh(D) negative women | 300 mcg | Intramuscularly | Single dose at any gestation for Rh(D) negative, antibody negative women within 72 hours of spontaneous bleeding or abdominal trauma. Single dose at 2628 weeks gestation for Rh(D) negative, antibody negative women. Single dose for Rh(D) negative, antibody negative women within 72 hours of delivery of Rh(D) positive infant, or infant with unknown blood type,. |
Epinephrine HCL | Post-exposure treatment of severe allergic reaction to approved medication | 0.3 to 0.5 in a concentration of 1:1000 | Intramuscular injection into anterolateral aspect of the thigh or via metered dose auto-injector | Seek medical attention immediately after administration of first injection. Can be given every 5-15 minutes as needed for 3 to 4 doses. |
Tranexamic Acid (TXA) To be used when initial anti-hemorrhagic therapies fail and with notification of local medical support | Control of Postpartum Hemorrhage | 100mg/ml (1 g) | IV at 1 ml per minute | 2nd dose if bleeding continues past 30 minutes or restarts with 24 hours. |
IV Fluids * Lactate Ringers (LR) * .45% Saline * .9% Normal Saline | To treat maternal hemorrhage | Infuse 1 liter in wide-open rate | IV line with 16 18 gauge needle | After first liter, a second liter may be titrated to client's condition. |
S.D. Admin. R. tit. 20, art. 20:86, ch. 20:86:03, app A
General Authority: SDCL 36-9C-32(2)
Law Implemented: SDCL 36-9C-13(7)